Kempen, Nomura are managers; offering to finance product development
By Devika Patel
Knoxville, Tenn., April 5 - MDxHealth SA said it raised €8.16 million in a private placement of shares. The offering was announced Tuesday, when the company said it would raise about €6 million.
The company sold 5,436,713 ordinary shares apiece at €1.50 per share. The price per share is a 28.23% discount to the April 4 closing share price, €2.09.
Kempen & Co and Nomura Code Securities are joint lead managers and joint bookrunners and ING Belgium is co-lead manager for the offering.
Settlement is expected April 8.
Proceeds will be used to accelerate product development in line with the new business strategy and to set up a CLIA laboratory and hire a sales and marketing team in the United States.
MDxHealth is a Liege, Belgium, molecular diagnostics company.
| Issuer: | MDxHealth SA
|
| Issue: | Ordinary shares
|
| Amount: | €8,155,070
|
| Shares: | 5,436,713
|
| Price: | €1.50
|
| Managers: | Kempen & Co and Nomura Code Securities (joint lead managers and bookrunners) and ING Belgium (co-lead manager)
|
| Warrants: | No
|
| Announcement date: | April 5
|
| Settlement date: | April 8
|
| Stock symbol: | Brussels: MDXH
|
| Stock price: | €2.09 at close April 5
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
